Global Eubiotics Market Size, Share, Growth Analysis Report - Forecast 2034

Eubiotics Market

Eubiotics Market By Product Type (Probiotics, Prebiotics, Organic Acids, Essential Oils), By Form (Dry, Liquid), By Livestock (Poultry, Swine, Ruminants, Aquaculture, Others), By Function (Gut Health, Immunity Boosting, Performance Enhancement), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Pharmaceutical Report Format : PDF Pages: 193 Report Code: ZMR-1313 Published Date: Jun-2025 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 5.86 Billion USD 13.86 Billion 9% 2024

Industry Prospect:

The global eubiotics market size was worth around USD 5.86 Billion in 2024 and is predicted to grow to around USD 13.86 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 9% between 2025 and 2034. The report analyzes the global eubiotics market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the enterprise data management market.

Global Eubiotics Market  sizeRequest Free Sample

Eubiotics Market: Overview

Eubiotics are essential feed additives that are widely used to maintain and even enhance the digestive health of poultry, swine, livestock, and aquatic animals. They are extensively used as a natural digestive stimulant and are used as a great alternative to antibiotics in the feed. Animal eubiotics play a major role in providing necessary nutrient absorption, enhancing immunity, and increasing overall performance for livestock for the production of well-nourished animals. Besides, eubiotics maintain a healthy blend of microbiota such as fungi, protists, bacteria, and archaea in the gastrointestinal tract of animals.

Key Insights

  • As per the analysis shared by our research analyst, the global eubiotics market is estimated to grow annually at a CAGR of around 9% over the forecast period (2025-2034).
  • Regarding revenue, the global eubiotics market size was valued at around USD 5.86 Billion in 2024 and is projected to reach USD 13.86 Billion by 2034.
  • The eubiotics market is projected to grow at a significant rate due to ban on antibiotic growth promoters, rising demand for gut health in livestock, and growing awareness of animal welfare.
  • Based on Product Type, the Probiotics segment is expected to lead the global market.
  • On the basis of Form, the Dry segment is growing at a high rate and will continue to dominate the global market.
  • Based on the Livestock, the Poultry segment is projected to swipe the largest market share.
  • By Function, the Gut Health segment is expected to dominate the global market.
  • Based on region, North America is predicted to dominate the global market during the forecast period.

Global Eubiotics MarketRequest Free Sample

To know more about this report, request a sample copy.

Eubiotics Market: Drivers

Increase in demand for better feed quality, nutrition, and protein for animals drives the growth of the market

There has been a significant surge in the livestock population base, and hence the importance of providing better feed quality to animals has gained immense traction due to a gradual increase in the consumption of meat among people across the globe. Animal feed that contains better nutrition and proteins has a favorable impact on the gut health, immunity system, and overall performance of the animal. Besides, an increase in awareness about the application of various natural compounds of eubiotics rather than antibiotic growth promoters (AGPs) drive the growth of the global eubiotics market during the forecast period.

Eubiotics Market: Restraints

Imposition of stringent rules and regulations toward product approvals may restrict the growth of the market

Stringent rules and regulations are imposed by the government of various nations regarding the application and approval of various eubiotic products. This further results in trade complexities that may restrict the growth of the eubiotic industry during the forecast period. In addition, the extortionate cost of producing various eubiotic compounds may also obstruct the growth of the market. Furthermore, low awareness about the efficiency of the product among people and several complications in food production chains further impede the growth of the market during the forecast period.

Eubiotics Market: Opportunities

Increase in investment and expenditure for research and development proficiencies offers remunerative opportunities for the growth of the market

There has been a remarkable increase in investment and expenditure for animal consumption and research development for maintaining their and people’s health leading to large-scale industrialization of the livestock industry. In countries, such as India, China, and Japan, animal husbandry has gained massive traction and has been revamped into a thoroughly diversified activity. This was done by effectively highlighting the scientific management of farm animals, which would save costs and enhance productivity. These factors are expected to create ample opportunities for the growth of the industry.

Eubiotics Market: Challenges

Growing cases of disease outbreaks in livestock can act as a major challenge to the growth of the market

Increase in the cases of diseases in livestock is not only a threat to the health of the animals but also to human health due to increased animal consumption among us. Livestock is susceptible to various diseases such as H5N1 avian influenza, Q fever, Bovine spongiform encephalopathy, Nipah Virus, and bovine tuberculosis. These outbreaks in livestock can have a negative impact on the animal population, resulting in the reduction of herd productivity. Thus, disease outbreaks in livestock can have an adverse impact on the global food supply and human health, and local and worldwide economies.

Eubiotics Market: Segmentation

The global eubiotics market is segmented based on type, form, livestock, function, and region.

Based on type, the global market is bifurcated into probiotics, prebiotics, essential oils, organic acids, and others. The probiotics segment held the largest market share in 2024, holding nearly 40% of the global market share, and is further expected to grow at a promising CAGR during the forecast period. The main reason for the growth of this segment is the increase in awareness about the application of probiotics in animal feed among people. Probiotics are essentially used in animal feed due to a bunch of benefits it provides such as improved gut health, better productivity, necessary immunity development, and enhancement of overall performance in animals.

In addition, a remarkable surge in research and development activities to create innovative, effective products and the availability of a wide range of product offerings from eminent players in the market further drive the growth of the segment during the forecast period.

Based on form, the global market is segmented into solid and liquid. The solid form segment held the dominating market share in 2024, occupying about 60.12%, and is further expected to grow at a promising CAGR during the forecast period. Solid forms usually include beadlet, cross-linked beadlet, and flakes. The high market share of this segment is mainly attributed to the improved protection of solid form from intermittent exposure to light and sunlight. Besides, the effective use of beadlet technology aids in preserving the active ingredients from heat and mechanical stress so as to make them sturdier and absorbable in feed production for animals.

By Livestock, the global eubiotics market is split into Poultry, Swine, Ruminants, Aquaculture, Others.

In terms of Function, the global eubiotics market is categorized into Gut Health, Immunity Boosting, Performance Enhancement.

Recent Developments:

  • In July 2021, Koninklijke DSM N.V, a Netherlands-based multinational corporation that is engaged in the fields of materials, health and nutrition, announced that they have acquired Midori USA, Inc., a biotechnological start-up company that is engaged in developing innovative targeted eubiotics that significantly enhance the environmental impact and health of the animals. The use of eubiotics has gained massive traction since farming practices have strived to become more sustainable, apart from adopting antibiotic alternatives. DSM mentioned that they are working to launch, Symphiome, its first targeted glycan with Midori, which will be the first product from the collaboration. It is specially created to greatly influence functional modulation of the gut microbiome so as to appreciably ameliorate gut health and feed efficiency whilst exempting from the use of antibiotics. It will also reduce wasteful emissions from animal farming.
  • In January 2021, Novus International, Inc., a dominant player that provides nutrition and health solutions in the animal agriculture industry, announced that they have partnered with Agrivida, a Massachusetts-based biotech innovator, in order to expand their customer base as well as implore pristine and creative products and solutions with the help of R&D collaboration.

Eubiotics Market: Report Scope

Report Attributes Report Details
Report Name Eubiotics Market
Market Size in 2024 USD 5.86 Billion
Market Forecast in 2034 USD 13.86 Billion
Growth Rate CAGR of 9%
Number of Pages 193
Key Companies Covered DSM, Novozymes, Kemin Industries, Inc., Roquette Frères, FrieslandCampina, Neospark Drugs and Chemicals Private Limited, ASAHI GROUP HOLDINGS, Ltd., Lesaffre, MSPrebiotics Inc., ADM, Lallemand Inc., BEHN MEYER, NOVUS INTERNATIONAL, BENEO, Yara, Cargill, Incorporated, BASF SE, Chr. Hansen Holding A/S, and ADDCON GmbH among other global players., and others.
Segments Covered By Product Type, By Form, By Livestock, By Function, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA)
Base Year 2024
Historical Year 2020 to 2023
Forecast Year 2025 - 2034
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization
 

Eubiotics Market: Regional Analysis

Europe to hold lion’s share in the global industry  

The Europe region held the largest global eubiotics market share in 2024, holding over 42% of the market share, and is further expected to grow exponentially at a significant CAGR during the forecast period. The major reason for the growth of the market in this region is that countries major European countries such as Italy, Germany, and France have witnessed a notable increase in the consumption of meat over the past couple of years. There has been an increase in the production of livestock in the region to meet the growing demand of the people as consumption of processed food in the form of meat is also on the rise, which drives the growth of the market in the region. Thus, more and more producers in the region are corroborating disease-free, superior animal products that bolster the growth of the market in the region during the forecast period.

Eubiotics Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the eubiotics market on a global and regional basis.

The global eubiotics market is dominated by players like:

  • DSM
  • Novozymes
  • Kemin Industries Inc.
  • Roquette Frères
  • FrieslandCampina
  • Neospark Drugs and Chemicals Private Limited
  • ASAHI GROUP HOLDINGS Ltd.
  • Lesaffre
  • MSPrebiotics Inc.
  • ADM
  • Lallemand Inc.
  • BEHN MEYER
  • NOVUS INTERNATIONAL
  • BENEO
  • Yara
  • Cargill Incorporated
  • BASF SE
  • Chr. Hansen Holding A/S
  • and ADDCON GmbH among other global players.

The global eubiotics market is segmented as follows;

By Product Type

  • Probiotics
  • Prebiotics
  • Organic Acids
  • Essential Oils

By Form

  • Dry
  • Liquid

By Livestock

  • Poultry
  • Swine
  • Ruminants
  • Aquaculture
  • Others

By Function

  • Gut Health
  • Immunity Boosting
  • Performance Enhancement

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Table Of Content

Methodology

FrequentlyAsked Questions

The global eubiotics market is expected to grow due to ban on antibiotic growth promoters, rising demand for gut health in livestock, and growing awareness of animal welfare.

According to a study, the global eubiotics market size was worth around USD 5.86 Billion in 2024 and is expected to reach USD 13.86 Billion by 2034.

The global eubiotics market is expected to grow at a CAGR of 9% during the forecast period.

North America is expected to dominate the eubiotics market over the forecast period.

Leading players in the global eubiotics market include DSM, Novozymes, Kemin Industries, Inc., Roquette Frères, FrieslandCampina, Neospark Drugs and Chemicals Private Limited, ASAHI GROUP HOLDINGS, Ltd., Lesaffre, MSPrebiotics Inc., ADM, Lallemand Inc., BEHN MEYER, NOVUS INTERNATIONAL, BENEO, Yara, Cargill, Incorporated, BASF SE, Chr. Hansen Holding A/S, and ADDCON GmbH among other global players., among others.

The report explores crucial aspects of the eubiotics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.

Choose License Type

  • zion payment modes

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed